Search - tctmd.com

Displaying 81 - 100 of 305

Sort: Relevancy | Date

News Conference News AHA 2022

High-Sensitivity Troponin Testing on the Rise in the US but Still Limited

Michael O'Riordan

November 04, 2022

News Daily News

Most Patient-Reported Outcome Measures in CVD Fall Short

L.A. McKeown

September 23, 2022

News Conference News TCT 2022

HF Devices Have a Role to Play, Even With Today’s GDMT Bonanza

Todd Neale

September 16, 2022

News Conference News ESC 2022

Large RCTs of High-Dose Flu Vaccines Doable, DANFLU-1 Confirms

Yael L. Maxwell

August 31, 2022

News Daily News

Higher Annual TAVI Volumes Linked to Greater Use of Embolic Protection

L.A. McKeown

August 23, 2022

News Features

Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD?

Michael O'Riordan

August 15, 2022

News Conference News TVT 2022

Non-COAPT-Like Patients Fare Well With MitraClip, EXPAND Suggests

Michael O'Riordan

June 09, 2022

News Daily News

FDA Approves Mavacamten for Obstructive Hypertrophic Cardiomyopathy

Michael O'Riordan

April 29, 2022

News Daily News

Postmarketing Studies of CV Devices Still Lacking in the US

Caitlin E. Cox

March 17, 2022

News Daily News

FDA Approves Empagliflozin for Treatment of HFpEF

Michael O'Riordan

February 24, 2022

News Daily News

FDA Grants Expanded Indication to CardioMEMS PA Pressure Monitor

Shelley Wood

February 22, 2022

News Daily News

Robert M. Califf Becomes 25th Commissioner of the US FDA

L.A. McKeown

February 15, 2022

News Features

Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path

Michael O'Riordan

January 17, 2022

News Daily News

TCTMD’s Top 10 Most Popular Stories for December 2021

Caitlin E. Cox

December 29, 2021

News Daily News

COVID-19: TCTMD’s Dispatch for December Week 4

Todd Neale

December 27, 2021

News Daily News

FDA Approves Two Additional Indications for Rivaroxaban in Children

L.A. McKeown

December 21, 2021

News Daily News

FDA Clears SAPIEN 3 With Alterra Prestent for Pulmonary Valve Replacement

L.A. McKeown

December 20, 2021

News Daily News

British Medical Groups Express Concern About Inclisiran Rollout

Michael O'Riordan

December 14, 2021

News Daily News

COVID-19: TCTMD’s Dispatch for October Week 4

Todd Neale

October 25, 2021

News Opinion Off Script

Restarting In-Person Interventional Meetings: A Delicate but Necessary Juggling Act

Juan F. Granada, MD

October 14, 2021

Advertisement

High-Sensitivity Troponin Testing on the Rise in the US but Still Limited

Most Patient-Reported Outcome Measures in CVD Fall Short

HF Devices Have a Role to Play, Even With Today’s GDMT Bonanza

Large RCTs of High-Dose Flu Vaccines Doable, DANFLU-1 Confirms

Higher Annual TAVI Volumes Linked to Greater Use of Embolic Protection

Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD?

Non-COAPT-Like Patients Fare Well With MitraClip, EXPAND Suggests

FDA Approves Mavacamten for Obstructive Hypertrophic Cardiomyopathy

Postmarketing Studies of CV Devices Still Lacking in the US

FDA Approves Empagliflozin for Treatment of HFpEF

FDA Grants Expanded Indication to CardioMEMS PA Pressure Monitor

Robert M. Califf Becomes 25th Commissioner of the US FDA

Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path

TCTMD’s Top 10 Most Popular Stories for December 2021

COVID-19: TCTMD’s Dispatch for December Week 4

FDA Approves Two Additional Indications for Rivaroxaban in Children

FDA Clears SAPIEN 3 With Alterra Prestent for Pulmonary Valve Replacement

British Medical Groups Express Concern About Inclisiran Rollout

COVID-19: TCTMD’s Dispatch for October Week 4

Restarting In-Person Interventional Meetings: A Delicate but Necessary Juggling Act

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content